{"filing":{"accession_number":"0001213900-26-080011","cik":"0001812173","ticker":"RBOTW","company_name":"Vicarious Surgical Inc.","form":"8-K","filing_date":"2026-07-21","report_date":null,"primary_document":"ea0298707-8k_vicarious.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390026080011/ea0298707-8k_vicarious.htm"},"events":[{"id":19116,"run_id":17204,"accession_number":"0001213900-26-080011","anchor_item_number":"1.01","event_type":"bankruptcy_filing","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"Vicarious Surgical Inc. entered into a general assignment for the benefit of creditors (ABC) on July 21, 2026, transferring substantially all assets to a liquidation entity. This non-judicial insolvency proceeding is functionally equivalent to bankruptcy and represents a terminal event materially threatening the registrant's continued existence.","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":[{"id":18114,"accession_number":"0001213900-26-080011","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"bankruptcy_filing","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The Company entered into a general assignment for the benefit of creditors (ABC) on July 21, 2026, transferring substantially all assets to a liquidation entity. An ABC is a non-judicial insolvency proceeding functionally equivalent to bankruptcy—a terminal event materially threatening the registrant's continued existence. The stockholder approval and Board authorization of this liquidation arrangement constitute a bankruptcy-equivalent filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"","ticker":null,"filing_date":""},{"id":18115,"accession_number":"0001213900-26-080011","item_number":"2.01","item_title":"Completion of Acquisition or Disposition","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Item 2.01 explicitly discloses completion of an acquisition or disposition of assets. The section references an Assignment Agreement and Assignment incorporated from Item 1.01, indicating a material transaction involving transfer of assets has been completed. This is a core M\u0026A event requiring disclosure under Item 2.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"","ticker":null,"filing_date":""},{"id":18118,"accession_number":"0001213900-26-080011","item_number":"8.01","item_title":"Other Events.","event_type":"terminal_other","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The disclosure describes the Board's determination to voluntarily deregister the company's common stock via Form 15 filing and stockholder-approved voluntary dissolution and liquidation of Vicarious Surgical, with the Certificate of Dissolution to be filed with Delaware on July 22, 2026. This is a terminal event materially threatening the registrant's continued existence—the company is dissolving and ceasing operations. While not a bankruptcy filing, this represents the company's end as a going concern and is the most existential event possible for a public company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":19117,"run_id":17204,"accession_number":"0001213900-26-080011","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Stockholders voted on July 21, 2026 to approve an assignment for the benefit of creditors followed by voluntary dissolution and liquidation, with 13,348,600 votes in favor, 100,879 against, and 44,093 abstentions (69% quorum of outstanding voting power).","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":[{"id":18117,"accession_number":"0001213900-26-080011","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This disclosure reports the results of a special shareholder meeting held on July 21, 2026, where stockholders voted on a proposal to approve an assignment for the benefit of creditors followed by voluntary dissolution and liquidation. The vote tally (13,348,600 for, 100,879 against, 44,093 abstentions) and quorum information (69% of outstanding voting power) are clearly presented, matching the Item 5.07 requirement for shareholder vote results. This is material as it concerns a potential liquidation event that would fundamentally affect the company's continued existence.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":19118,"run_id":17204,"accession_number":"0001213900-26-080011","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"All seven board members resigned effective upon Form 15 filing, and four key executives—CEO Stephen From, President Adam Sachs, CTO Sammy Khalifa, and Chief Medical Officer Dr. Barry Greene—were terminated effective July 21, 2026, in connection with the company's liquidation.","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":[{"id":18116,"accession_number":"0001213900-26-080011","item_number":"5.02","item_title":"Departure of Directors or Certain Officers;","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the resignation of all seven board members effective upon Form 15 filing, and the termination of four key executives (CEO Stephen From, President Adam Sachs, CTO Sammy Khalifa, and Chief Medical Officer Dr. Barry Greene) effective July 21, 2026. While severance arrangements are mentioned, the principal disclosed action is the departure of these officers and directors, which is material to investors assessing leadership continuity and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18114,"accession_number":"0001213900-26-080011","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"bankruptcy_filing","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The Company entered into a general assignment for the benefit of creditors (ABC) on July 21, 2026, transferring substantially all assets to a liquidation entity. An ABC is a non-judicial insolvency proceeding functionally equivalent to bankruptcy—a terminal event materially threatening the registrant's continued existence. The stockholder approval and Board authorization of this liquidation arrangement constitute a bankruptcy-equivalent filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21"},{"id":18115,"accession_number":"0001213900-26-080011","item_number":"2.01","item_title":"Completion of Acquisition or Disposition","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Item 2.01 explicitly discloses completion of an acquisition or disposition of assets. The section references an Assignment Agreement and Assignment incorporated from Item 1.01, indicating a material transaction involving transfer of assets has been completed. This is a core M\u0026A event requiring disclosure under Item 2.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21"},{"id":18116,"accession_number":"0001213900-26-080011","item_number":"5.02","item_title":"Departure of Directors or Certain Officers;","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the resignation of all seven board members effective upon Form 15 filing, and the termination of four key executives (CEO Stephen From, President Adam Sachs, CTO Sammy Khalifa, and Chief Medical Officer Dr. Barry Greene) effective July 21, 2026. While severance arrangements are mentioned, the principal disclosed action is the departure of these officers and directors, which is material to investors assessing leadership continuity and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21"},{"id":18117,"accession_number":"0001213900-26-080011","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This disclosure reports the results of a special shareholder meeting held on July 21, 2026, where stockholders voted on a proposal to approve an assignment for the benefit of creditors followed by voluntary dissolution and liquidation. The vote tally (13,348,600 for, 100,879 against, 44,093 abstentions) and quorum information (69% of outstanding voting power) are clearly presented, matching the Item 5.07 requirement for shareholder vote results. This is material as it concerns a potential liquidation event that would fundamentally affect the company's continued existence.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21"},{"id":18118,"accession_number":"0001213900-26-080011","item_number":"8.01","item_title":"Other Events.","event_type":"terminal_other","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The disclosure describes the Board's determination to voluntarily deregister the company's common stock via Form 15 filing and stockholder-approved voluntary dissolution and liquidation of Vicarious Surgical, with the Certificate of Dissolution to be filed with Delaware on July 22, 2026. This is a terminal event materially threatening the registrant's continued existence—the company is dissolving and ceasing operations. While not a bankruptcy filing, this represents the company's end as a going concern and is the most existential event possible for a public company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:12:07.404988+00:00","company_name":"Vicarious Surgical Inc.","ticker":"RBOTW","filing_date":"2026-07-21"}]}